Mitsuhashi, Akira <br/><br/>
Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.  [electronic resource] 

 -  Cancer  Oct 2014 
 - 2986-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.28853  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Adult<br/>Aged<br/>Antigens, Neoplasm--metabolism<br/>Antineoplastic Agents--therapeutic use<br/>Blotting, Western<br/>Carcinoma, Endometrioid--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Chemotherapy, Adjuvant<br/>DNA Topoisomerases, Type II--metabolism<br/>DNA-Binding Proteins--metabolism<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Immunohistochemistry<br/>Ki-67 Antigen--metabolism<br/>MAP Kinase Signaling System<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase Kinases--metabolism<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Prospective Studies<br/>Ribosomal Protein S6--metabolism<br/>TOR Serine-Threonine Kinases--metabolism